Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CTH | P32929 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9509093 | 0.85 | LDHA (0.44) | LDHASRRCYP2D6CYP2C19CTH | |
| SCHEMBL8119872 | 0.84 | — | — | |
| SCHEMBL509266 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL899427 | 0.82 | — | — | |
| SCHEMBL3464176 | 0.80 | LMNA (0.47) | LDHASRRCYP2D6CYP2C19CTH | |
| SCHEMBL28074944 | 0.80 | — | — | |
| SCHEMBL5800110 | 0.80 | — | — | |
| SCHEMBL8119372 | 0.80 | — | — | |
| SCHEMBL432430 | 0.79 | — | — | |
| SCHEMBL1264310 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099243-A1 | MODIFIED AND UNMODIFIED PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN THE TREATMENT OR PREVENTION OF CEREBRAL HYPOPERFUSION FOR THE IMPROVEMENT OF CEREBRAL BLOOD FLOW (CBF) | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2025133203-A1 | COMPOUNDS AND METHODS FOR A LONG-LASTING PAM | PAM THERAGNOSTICS GMBH (DE) | 2025-06-26 | — | — | WO | claimed |
| CN-119233973-A | Pharmaceutical compound and application thereof | 映恩生物制药（苏州）有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118006093-A | Polyethylene glycol succinate compound and preparation method thereof | 中国石油大学(北京) | 2024-05-10 | — | — | CN | claimed |
| US-20240131227-A1 | MULTIFUNCTIONAL SEALING MEMBER FOR IMPROVED ENDOTHELIALIZATION AND PARAVALVULAR LEAKAGE | EDWARDS LIFESCIENCES CORP (US) | 2024-04-25 | — | — | US | claimed |
| EP-4355267-A1 | MULTIFUNCTIONAL SEALING MEMBER FOR IMPROVED ENDOTHELIALIZATION AND PARAVALVULAR LEAKAGE | Edwards Lifesciences Corporation (US) | 2024-04-24 | — | — | EP | claimed |
| WO-2023232142-A1 | PHARMACEUTICAL COMPOUND AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-12-07 | — | — | WO | claimed |
| CN-115261245-B | Root nodule strain capable of inducing plants to have salt tolerance and application thereof | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 2023-09-19 | — | — | CN | claimed |
| WO-2023085882-A1 | ADMINISTRATION THERAPY OF INTERLEUKIN-7 FUSION PROTEIN FOR TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIOUS DISEASE | 주식회사 제넥신 | 2023-05-19 | — | — | WO | claimed |
| WO-2022266119-A1 | MULTIFUNCTIONAL SEALING MEMBER FOR IMPROVED ENDOTHELIALIZATION AND PARAVALVULAR LEAKAGE | EDWARDS LIFESCIENCES CORPORATION (US) | 2022-12-22 | — | — | WO | claimed |
| WO-2022135332-A1 | STEROID CONJUGATE | 映恩生物制药（苏州）有限公司 | 2022-06-30 | — | — | WO | claimed |
| WO-1999021587-A1 | COMPLEXING AGENTS AND TARGETING IMMUNOREAGENTS | NYCOMED IMAGING AS (NO) | 1999-05-06 | — | — | WO | claimed |
| US-5516645-A | Immunoassay analytical elements containing vanadium IV(V+4)ions | JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. (US) | 1996-05-14 | — | — | US | claimed |
| US-5367080-A | PYRIDINE DERIVATIVES | STERLING WINTHROP INC. (US) | 1994-11-22 | — | — | US | claimed |
| US-4837169-A | RADIOIMMUNOASSAY | EASTMAN KODAK COMPANY (US) | 1989-06-06 | — | — | US | claimed |
| EP-0288256-A2 | Fluorescent labels | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-10-26 | — | — | EP | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | disclosed |
| US-4859777-A | Terpyridine chelating agents | EASTMAN KODAK COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| US-4837169-A | RADIOIMMUNOASSAY | EASTMAN KODAK COMPANY (US) | 1989-06-06 | — | — | US | disclosed |